5//SEC Filing
Reynolds Sharon L 5
Accession 0001382756-10-000001
CIK 0001004724other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 10:37 AM ET
Size
23.2 KB
Accession
0001382756-10-000001
Insider Transaction Report
Form 5
Reynolds Sharon L
VP Skilled Nursing
Transactions
- Award
Common Stock
2009-12-07+1,520→ 5,320 total - Other
Warrants
2009-12-07−1,520→ 31,080 totalFrom: 2012-11-16Exp: 2017-11-16→ Common Stock (1,520 underlying) - Award
Warrants
2009-12-07+25,000→ 31,080 totalExercise: $3.00Exp: 2014-12-07→ Common Stock (25,000 underlying)
Holdings
- 9,640
Options
Exercise: $2.50From: 2007-08-27Exp: 2012-08-27→ Common Stock (880 underlying) - 9,640
Options
Exercise: $2.50From: 2005-08-27Exp: 2010-08-27→ Common Stock (880 underlying) - 9,640
Options
Exercise: $2.50From: 2006-08-27Exp: 2011-08-27→ Common Stock (880 underlying) - 9,640
Options
Exercise: $1.50From: 2008-05-09Exp: 2013-05-09→ Common Stock (1,400 underlying) - 9,640
Options
Exercise: $1.50From: 2010-05-09Exp: 2011-05-09→ Common Stock (1,400 underlying) - 9,640
Options
Exercise: $1.50From: 2011-05-09Exp: 2016-05-09→ Common Stock (1,400 underlying) - 5,320
Common Stock
- 9,640
Options
Exercise: $1.50From: 2007-05-09Exp: 2012-05-09→ Common Stock (1,400 underlying) - 9,640
Options
Exercise: $1.50From: 2009-05-09Exp: 2014-05-09→ Common Stock (1,400 underlying) - 31,080
Warrants
Exp: 2017-11-16→ Common Stock (6,080 underlying)
Footnotes (4)
- [F1]On August 15, 2008 the shareholders approved an incentive plan which granted warrants to certain officers and directors. The warrants vested over a five year period. On December 7, 2009 the shareholders approved an amendment to the incentive plan to eliminate 218,461 unvested warrants. The amendment further called for 218,461 shares of the Company's common stock with a one year restriction on transfer to be issued.
- [F2]The exercise price of the warrants vested in 2008 was $1.21 per share, those vested in 2009 was $2.25, those vested in 2010 was $3.00 and those vesting in 2011 is $4.00 per share.
- [F3]The exercise price of the warrants was based upon the average closing price of the Company's common stock on NYSE-Amex during January 2011 but not less than $3.00.
- [F4]On December 7, 2009 the shareholders approved the award of 25,000 warrants to the senior management of the Company. The warrants vest over a two year period. One-third of the warrants will vest upon issuance, with the remaining warrants vesting equally over the next two years; provided, however that the vesting would be accelerated in the event that there is a change in control of the Company or in the event the recipient is terminated by the Company without cause. The warrants will be exercisable on a cashless basis.
Documents
Issuer
ADCARE HEALTH SYSTEMS INC
CIK 0001004724
Entity typeother
Related Parties
1- filerCIK 0001382756
Filing Metadata
- Form type
- 5
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 10:37 AM ET
- Size
- 23.2 KB